Jazz lifted by third EU approval for GW Pharma’s EpidyolexGW Pharmaceuticals’ Epidyolex has been approved in the EU for a third epilepsy indication, giving a boost for Share XJazz lifted by third EU approval for GW Pharma’s Epidyolexhttps://pharmaphorum.com/news/jazz-lifted-by-third-eu-approval-for-gw-pharmas-epidyolex/
GW confident epilepsy drug will get NHS funding despite NICE rejectionThe UK’s GW Pharma has insisted there will be no repeat of the controversy seen with cystic fibrosis Share XGW confident epilepsy drug will get NHS funding despite NICE rejectionhttps://pharmaphorum.com/news/no-repeat-of/
